PTC Therapeutics Inc. (PTCT)
NASDAQ: PTCT
· Real-Time Price · USD
48.40
-0.30 (-0.62%)
At close: Aug 15, 2025, 3:04 PM
PTC Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 178.88M | 1.18B | 213.17M | 196.79M | 186.7M | 210.12M | 307.06M | 196.58M | 213.81M | 220.38M | 167.41M | 217.13M | 165.53M | 148.74M | 165.23M | 138.74M | 116.68M | 117.94M |
Cost of Revenue | 15.48M | 12.86M | -38.11M | 10.85M | 18.39M | 66.27M | 106.29M | 9.49M | 12.73M | 14.14M | 10.89M | 14.01M | 9.64M | 10.13M | 9.33M | 6.54M | 7.36M | 9.1M |
Gross Profit | 163.39M | 1.16B | 251.28M | 185.94M | 168.31M | 143.85M | 200.76M | 187.08M | 201.08M | 206.24M | 156.52M | 203.12M | 155.89M | 138.6M | 155.9M | 132.2M | 109.32M | 108.84M |
Operating Income | -34.96M | 970.23M | -162.39M | -54.51M | -33.36M | -45.55M | 3.12M | -118.16M | -209.54M | -115.22M | -200.34M | -73.49M | -107.56M | -86.52M | -84.73M | -93.08M | -98.49M | -98.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -71.05M | 929.83M | -94.7M | -97.99M | -85.73M | -84.7M | -157.05M | -166.59M | -237.48M | -134.99M | -189.69M | -127.21M | -148.69M | -121.89M | -138.61M | -133.66M | -117.88M | -128.19M |
Net Income | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M | -91.58M | -155.79M | -132.97M | -198.88M | -138.96M | -170.89M | -109.31M | -152.09M | -126.73M | -143.26M | -133.62M | -118.37M | -128.64M |
Selling & General & Admin | 85.26M | 80.96M | 84.68M | 73.46M | 69.5M | 73.27M | 76.29M | 80.89M | 88.45M | 86.91M | 92.72M | 80.12M | 79.89M | 73.27M | 86.55M | 69.25M | 68.88M | 61.09M |
Research & Development | 112.99M | 108.97M | 124.77M | 161.41M | 132.17M | 116.13M | 121.35M | 164.21M | 185.87M | 195.12M | 188.69M | 165.46M | 157.26M | 140.08M | 149.84M | 130.84M | 125.48M | 134.51M |
Other Expenses | n/a | 3.08M | 25.05M | 5.58M | n/a | n/a | n/a | 60.15M | 1.48M | 39.41M | 75.45M | 31.02M | 26.29M | -11.86M | -31.38M | -18.78M | 3.17M | -10.88M |
Operating Expenses | 198.25M | 193.01M | 234.51M | 240.45M | 201.67M | 189.4M | 197.64M | 305.25M | 321.72M | 321.45M | 356.86M | 276.6M | 263.45M | 236.82M | 252.73M | 214.48M | 207.11M | 206.89M |
Interest Expense | 30.36M | 34.09M | 41.06M | 41.61M | 43.49M | 40.83M | 44.27M | 28.16M | 29.41M | 27.33M | 24.5M | 20.88M | 21.98M | 23.51M | 22.5M | 21.8M | 22.56M | 19.16M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -4.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 213.73M | 205.87M | 375.56M | 251.3M | 226.92M | 255.67M | 303.94M | 314.74M | 334.45M | 335.6M | 367.75M | 290.61M | 273.09M | 246.96M | 262.06M | 221.02M | 214.47M | 215.99M |
Income Tax Expense | -6.2M | 63.27M | -28.81M | 8.66M | 13.45M | 6.88M | -1.26M | -33.62M | -38.6M | 3.97M | -18.8M | -17.89M | 3.39M | 4.83M | 4.66M | -36K | 488K | 451K |
Shares Outstanding (Basic) | 78.15M | 78.12M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.45M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
Shares Outstanding (Diluted) | 78.15M | 86.39M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.65M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
EPS (Basic) | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 | -1.2 | -2.06 | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
EPS (Diluted) | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 | -1.2 | -2.06 | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
EBITDA | -34.96M | 970.23M | -46.88M | -49.9M | -35.23M | 11.53M | -32.07M | -73.89M | -154.33M | -61.89M | -126.33M | -68.64M | -95.15M | -70.16M | -95.42M | -93.26M | -78.49M | -98.15M |
EBIT | -40.69M | 963.92M | -53.64M | -56.38M | -42.24M | -43.86M | -112.78M | -138.43M | -208.06M | -107.66M | -165.19M | -106.33M | -126.72M | -98.38M | -116.11M | -111.86M | -95.32M | -109.03M |
Depreciation & Amortization | 7.58M | 7.22M | 6.76M | 6.49M | 7.02M | 55.4M | 80.7M | 64.54M | 53.74M | 45.77M | 38.87M | 37.69M | 31.57M | 28.22M | 20.68M | 18.6M | 16.83M | 15.41M |